DiaMedica Therapeutics In... (DMAC)

AI Score

Unlock

6.28

-0.25 (-3.83%)

At close: Mar 03, 2025, 3:59 PM

6.21

-1.11%

After-hours: Mar 03, 2025, 04:00 PM EST

DiaMedica Therapeutics Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04
Cash & Equivalents	4.54M	4.73M	4.71M	7.41M	3.88M	16.82M	1.35M	1.74M	165.69K	203.78K	2.52M	2.34M	2.65M	2.84M	629.53K	2.47M	3.5M	269.6K	274.76K	7.64K
Short-Term Investments	48.35M	28.77M	40.41M	20.1M	4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	271K	271K	0.00	-0.00	n/a	1.00	-0.09	0.08	0.42	n/a	1.00	n/a	1.00	1.00	n/a
Receivables	369K	82K	130K	340K	823K	780K	80K	51.97K	9.62K	8.41K	n/a	n/a	50.39K	220.95K	47.86K	31.11K	95.52K	57.06K	30.17K	19.97K
Inventory	n/a	n/a	113K	10K	88K	n/a	n/a	n/a	1.24	-0.00	1.00	n/a	1.00	1.00	1.00	1.00	1.00	0.68	2.00	n/a
Other Current Assets	411K	251K	197K	74K	135K	369K	61K	65.22K	32.92K	53.88K	81.67K	104.27K	33.7K	83.81K	17.23K	42.05K	50.06K	9.88K	13.49K	0.00
Total Current Assets	53.67M	33.84M	45.44M	27.92M	8.84M	17.97M	1.49M	1.85M	208.11K	266.03K	2.62M	2.46M	2.74M	3.14M	694.62K	2.54M	3.65M	336.54K	318.43K	27.61K
Property-Plant & Equipment	485K	560K	112K	174K	217K	96K	37K	19.39K	14.29K	15.56K	19.66K	6.59K	7.48K	8.89K	87.86K	99.78K	154.35K	13.07K	16.11K	19.55K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	269.27K	1.38M	3.58M	5.93M	462.99K	356.8K	535.67K	357.25K	228.06K	169.17K
Total Long-Term Assets	485K	560K	112K	174K	217K	367K	308K	19.39K	14.29K	15.56K	288.92K	1.38M	3.59M	5.94M	550.86K	456.58K	690.03K	370.32K	244.18K	188.72K
Total Assets	54.16M	34.4M	45.55M	28.09M	9.05M	18.34M	1.8M	1.87M	222.41K	281.59K	2.91M	3.85M	6.33M	9.08M	1.25M	3M	4.34M	706.86K	562.6K	216.33K
Account Payables	926K	734K	509K	1.1M	182K	483K	513K	250K	674.15K	959.98K	372.08K	1.13M	139.12K	n/a	n/a	n/a	272.38K	53.27K	56.49K	665.33K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	34K	n/a	-200.46K	33.03K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00
Short-Term Debt	83K	138K	98K	130K	120K	5K	n/a	n/a	261.43K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	168.18K
Other Current Liabilities	1.78M	1.3M	917K	791K	964K	774K	490K	376.97K	95.05K	851.68K	1.15M	449.72K	225.45K	554.1K	197.87K	218.01K	n/a	n/a	n/a	443.05K
Total Current Liabilities	2.79M	2.17M	1.52M	2.03M	1.32M	1.3M	1M	626.97K	1.06M	1.81M	1.52M	1.58M	364.56K	554.1K	197.87K	218.01K	272.38K	53.27K	56.49K	1.28M
Long-Term Debt	317K	800K	6K	106K	236K	36K	n/a	n/a	389.21K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	-400K	-3K	-53K	-118K	-18K	n/a	n/a	-1.03K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	317K	400K	3K	53K	118K	18K	n/a	n/a	388.17K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	3.1M	2.57M	1.53M	2.08M	1.44M	1.31M	1M	626.97K	1.45M	1.81M	1.52M	1.58M	364.56K	554.1K	197.87K	218.01K	272.38K	53.27K	56.49K	1.28M
Total Debt	400K	469K	52K	118K	178K	23K	n/a	200.46K	649.21K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	168.18K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	40.99M	28.05M	32.35K	33.57K	30.22K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-115.56M	-96.18M	-82.5M	-68.91M	-56.62M	-45.97M	-40.23M	-46.71M	-33.95M	-38.86M	-37.12M	-31.8M	-21.19M	-14.9M	-10.16M	-6.64M	-5.89M	-3.02M	-2.25M	-1.97M
Comprehensive Income	6K	-74K	-51K	-2K	2K	-24K	610.88K	587.08K	-20.92K	-20.09K	-19.21K	-15.8K	-10.66K	-8.02K	-94.98K	-57.4K	91.44K	-23.08K	-20.17K	13.58K
Shareholders Equity	51.06M	31.83M	44.02M	26.01M	7.62M	17.02M	799K	1.25M	-1.23M	-1.53M	1.38M	2.26M	5.96M	8.52M	1.05M	2.78M	4.06M	653.59K	506.11K	-1.06M
Total Investments	48.35M	28.77M	40.41M	20.1M	4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a